• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Prothena Corporation plc - Ordinary Shares (NQ:PRTA)

10.50 -0.08 (-0.76%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Prothena Corporation plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Prothena Corp Stock: A Deep Dive Into Analyst Perspectives (9 Ratings) ↗
February 24, 2025
 
Via Benzinga
News headline image
Prothena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business Highlights
February 20, 2025
From Prothena Corporation plc
Via Business Wire
News headline image
Earnings Scheduled For February 20, 2025 ↗
February 20, 2025
 
Via Benzinga
News headline image
Prothena to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
February 13, 2025
From Prothena Corporation plc
Via Business Wire
News headline image
Deep Dive Into Prothena Corp Stock: Analyst Perspectives (5 Ratings) ↗
February 07, 2025
 
Via Benzinga
News headline image
Demystifying Prothena Corp: Insights From 6 Analyst Reviews ↗
December 20, 2024
 
Via Benzinga
News headline image
Expert Ratings For Prothena Corp ↗
November 13, 2024
 
Via Benzinga
News headline image
Earnings Scheduled For November 12, 2024 ↗
November 12, 2024
 
Via Benzinga
News headline image
Earnings Preview For Prothena Corp ↗
November 11, 2024
 
Via Benzinga
News headline image
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket ↗
January 28, 2025
 
Via Benzinga
News headline image
Prothena Announces Board of Directors Update
December 30, 2024
From Prothena Corporation plc
Via Business Wire
News headline image
This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday ↗
December 20, 2024
 
Via Benzinga
Topics Stocks
News headline image
Prothena Catapults, Flashing A Bullish Sign, On Promise In Parkinson's Disease ↗
December 19, 2024
The drug technically missed the study's primary goal. But there's still promise it could work in specific patients. 
Via Investor's Business Daily
News headline image
Breaking Down Prothena Corp: 4 Analysts Share Their Views ↗
October 01, 2024
 
Via Benzinga
News headline image
Roche-Prothena Partnered Mid-Stage Parkinson's Trial Misses Primary Endpoint, But Cling On Signs Of Clinical Benefits ↗
December 19, 2024
Prothena and Roche report Phase 2b PADOVA results on prasinezumab in Parkinson's, showing promising trends and nominal significance in key analyses. 
Via Benzinga
News headline image
Accenture Posts Upbeat Results, Joins Darden Restaurants, CarMax And Other Big Stocks Moving Higher On Thursday ↗
December 19, 2024
 
Via Benzinga
News headline image
Roche’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible Clinical Benefit in Early-Stage Parkinson’s Disease
December 19, 2024
From Prothena Corporation plc
Via Business Wire
News headline image
Prothena Reports Third Quarter 2024 Financial Results and Business Highlights
November 12, 2024
From Prothena Corporation plc
Via Business Wire
News headline image
Prothena to Report Third Quarter 2024 Financial Results on November 12
November 05, 2024
From Prothena Corporation plc
Via Business Wire
News headline image
PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday ↗
October 28, 2024
 
Via Benzinga
News headline image
Dow Dips 300 Points; Emcore Shares Spike Higher ↗
September 30, 2024
 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
September 30, 2024
 
Via Benzinga
News headline image
Crude Oil Moves Higher; Prime Medicine Shares Spike Higher ↗
September 30, 2024
 
Via Benzinga
News headline image
Prothena Announces Leadership Team Updates
September 27, 2024
From Prothena Corporation plc
Via Business Wire
News headline image
Prothena to Participate in Upcoming Healthcare Conferences
August 29, 2024
From Prothena Corporation plc
Via Business Wire
News headline image
PRTA Stock Earnings: Prothena Corp Beats EPS, Beats Revenue for Q2 2024 ↗
August 08, 2024
PRTA stock results show that Prothena Corp beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Prothena Reports Second Quarter 2024 Financial Results and Business Highlights
August 08, 2024
From Prothena Corporation plc
Via Business Wire
News headline image
Prothena to Report Second Quarter 2024 Financial Results on August 8
August 01, 2024
From Prothena Corporation plc
Via Business Wire
News headline image
Eli Lilly Drags Alzheimer's Stocks Prothena, Eisai Lower Despite FDA Win ↗
June 11, 2024
An FDA panel unanimously backed Eli Lilly's Alzheimer's drug, but shares of Lilly and its rivals fell Tuesday. 
Via Investor's Business Daily
News headline image
Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration
May 28, 2024
From Prothena Corporation plc
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap